Afatinib slows relapse in NSCLC
An investigational oral drug delayed disease relapse for nearly a year in some patients with advanced non-small cell lung cancer (NSCLC).
An investigational oral drug delayed disease relapse for nearly a year in some patients with advanced non-small cell lung cancer (NSCLC).
by Dr Sunil Upadhyay – The role of bisphosphonates in the management of breast cancer with bone metastases is well established. However, their benefit in the adjuvant setting… read more.
by Dr Sunil Upadhyay – The majority of breast cancer patients diagnosed with oestrogen receptor positive tumours respond well to endocrine therapy like tamoxifen and aromatase inhibitors, when… read more.
by Dr Sunil Upadhyay – We know that atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in-situ (LCIS) and borderline DCIS/severe ADH are breast lesions which… read more.
by Dr Sunil Upadhyay – The San Antonio Breast Cancer Symposium 2011 was as exciting as ever with much new data and up-dates presented. Despite the ‘hot off… read more.
by Dr Sunil Upadhyay – Breast cancer is one of the most common malignancies in women all over the world and its complex and multi-factorial aetiology remains unclear…. read more.
by Dr Sunil Upadhyay – It is well known that HER2-positive marker positively regulates VEGF expression and VEGR levels correlate with HER2 over-expression. There is emerging evidence to… read more.
by Dr Sunil Upadhyay – There is clear evidence that the USA spends twice as much as any other country per GDP on cancer treatment but, except for… read more.
by Dr Sunil Upadhyay – Patients with HER2-positive tumours are known to carry a poor prognosis. The standard recommendation is that the majority of newly diagnosed patients with… read more.
by Dr Sunil Upadhyay – Age is the number one risk factor for the development of breast cancer. Not only the incidence but also the mortality from breast… read more.
by Dr Alison Louise Jones (pictured) – The headline figures are that the majority of women survive a diagnosis of breast cancer: 78% of those women currently diagnosed… read more.
Latest study says regular follow-up positive. Scientist say there is an urgent need for research into all aspects of follow-up care in lung cancer. The study presented in… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.